Myriad Genetics, Inc. (MYGN) Analyst Forecast

$8.06

north_east
$0.5 (6.61%)
Day's range
$7.6
Day's range
$8.11

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
11/04/2025 UBS Lu Li $8.00 $8.18   -2.2%
05/07/2025 Craig-Hallum Bill Bonello $18.00 $7.27   147.59%
05/07/2025 UBS Lu Li $7.00 $7.27   -3.71%
05/07/2025 Wells Fargo Brandon Couillard $6.00 $7.27   -17.47%
12/09/2024 Leerink Partners Puneet Souda $21.00 $15.15   38.61%
10/14/2024 Scotiabank Sung Ji Nam $34.00 $24.67   37.82%
09/19/2024 Morgan Stanley Tejas Savant $32.00 $28.47   12.4%
08/27/2024 Wells Fargo Brandon Couillard $35.00 $27.50   27.27%
08/07/2024 Guggenheim Subbu Nambi $29.00 $25.96   11.71%
06/26/2024 Scotiabank Sung Ji Nam $29.00 $24.62   17.79%
05/13/2024 Piper Sandler Jon Peterson $28.00 $25.07   11.69%
12/21/2023 Piper Sandler David Westenberg $23.00 $20.49   12.25%
10/05/2022 Stephens Mason Carrico $22.00 $20.82   5.67%

Myriad Genetics, Inc. FAQ's

Myriad Genetics, Inc. has been rated by research analysts at UBS, Craig-Hallum, Wells Fargo, Piper Sandler, Leerink Partners, Scotiabank in the past 90 days.